Data presented at the 2026 AACE Annual Meeting showed that EndoTool IV, Glooko’s inpatient glycemic management solution, achieved an impressive 98% reduction in severe hypoglycemia across a 19-hospital system compared to its historical paper protocols.

Glooko sponsored the second annual Diabetes Dash 5K Run, organized by the Dartmouth Diabetes Initiative, which raised over $8,500 for diabetes education.

At AACE 2026, Glooko presented data demonstrating that EndoTool IV achieved a 98% reduction in severe hypoglycemia across a 19-hospital health system when compared to historical paper protocols

By implementing the EndoTool predictive insulin-dosing platform, Temple Health achieved a two- to three-fold reduction in inpatient hypoglycemic events while improving patient safety and reducing clinician burden.

Per Grapatin, Vice President of Engineering at Glooko, shares how the digital health company migrated more than 100 million daily glucose readings in its diabetes management platform to Tiger Cloud to cut costs 40%, boost query speed 480x, and scale diabetes patient analytics.

During a Becker’s Healthcare webinar hosted by Glooko, four healthcare leaders explored where glycemic safety efforts commonly fall short and what it takes to build the consistency, standardization and infrastructure needed to close those gaps to meet new CMS guidelines.

The collaboration allows Accu-Chek’s CGM data to flow into the Glooko diabetes management platform, giving care teams a single dashboard to review glucose trends in select European markets.

Glooko is expanding its diabetes management platform capabilities by integrating the Roche Accu-Chek SmartGuide CGM across select European countries.

Glooko announced that it agreed to integrate its diabetes management platform with the Roche Accu-Chek SmartGuide CGM to reduce the administrative burden for healthcare teams and allow for the viewing of key insights in one place.

Glooko announced a new integration with Roche’s Accu-Chek SmartGuide CGM in select European countries, allowing patients to view their CGM data alongside other health metrics directly within the Glooko diabetes management platform.